Related by context. All words. (Click for frequent words.) 71 Ixempra 70 Nexavar sorafenib 69 Achieves Primary Endpoint 69 Completes Patient Enrollment 69 Meets Primary Endpoint 69 Campath alemtuzumab 68 Presents Preclinical 68 Regeneron Pharma 68 IG HCR ;) CO 68 paclitaxel Taxol ® 68 Tykerb lapatinib 68 evaluating tivozanib 68 Xeloda ® 68 PF # [002] 68 TELINTRA R 68 Fludara ® 68 Initiates Phase III 68 trastuzumab DM1 67 5 FU leucovorin 67 oral salmon calcitonin 67 AVASTIN 67 Initiates Enrollment 67 Erbitux cetuximab 67 Gemzar gemcitabine 67 Tesmilifene 67 Xelox 67 SPRYCEL ® 67 Temodar ® 67 gemcitabine Gemzar R 67 progressive metastatic prostate 67 Vion Pharmaceuticals 67 ImClone Erbitux 66 cetuximab Erbitux 66 Aflibercept 66 Initiates Clinical Trial 66 evaluating satraplatin 66 Initiates Phase 2b 66 dasatinib Sprycel 66 PTK# 66 Peginterferon alfa 2b 66 Vidaza R 66 Novartis VIRT X 66 refractory chronic lymphocytic 66 Pertuzumab 66 Canvaxin 66 Initiates Clinical 66 Roche Herceptin 66 trastuzumab Herceptin R 66 UCB Keppra 66 Pazopanib 66 lumiliximab 66 interferon gamma 1b 66 Gilead Sciences GILD.O 66 Initiates Phase II 66 Kosan dependence 66 TRACON Pharmaceuticals 65 AstraZeneca AZN.L 行情 65 Rheumatoid Arthritis Drug 65 Announces Tentative Approval 65 PRN FDA Approves 65 Panzem R 65 AAG geldanamycin analog 65 Genentech Herceptin 65 Receives Orphan Drug Designation 65 Bayer Nexavar 65 Merck KGaA Erbitux 65 docetaxel Taxotere R 65 Allovectin 7 65 Sutent sunitinib malate 65 Psoriasis Drug 65 Femara letrozole 65 Nexavar sorafenib tablets 65 BRAF inhibitor 65 Demonstrates Significant 65 Nexavar ® 65 Potelligent Technology 65 Pfizer Sutent 65 Transkaryotic Therapies TKTX 65 sorafenib Nexavar 65 SUTENT ® 65 regorafenib 65 TO AVOID PREGNANCY WHILE 65 Taxotere docetaxel 65 Submits Biologics License Application 65 Velcade bortezomib 65 MyVax R 65 chemotherapy FOLFOX 65 ZOLINZA 65 Vertex VRTX 65 Vertex telaprevir 65 Antibody Drug Conjugate 65 thalidomide Thalomid 65 LymphoStat B belimumab 65 SAN FP 65 R sorafenib tablets 65 FOLFOX6 chemotherapy regimen 65 sorafenib tablets 64 adalimumab Humira 64 Mg Usa 64 Trastuzumab DM1 64 AstraZeneca Iressa 64 virus HCV protease inhibitor 64 Vectibix panitumumab 64 Panzem NCD 64 R lenalidomide 64 MAGE A3 ASCI 64 Reports Preclinical Data 64 BioSante Pharmaceuticals Announces 64 Namenda Memantine HCl 64 Xeloda capecitabine 64 OSI Tarceva 64 Omnitarg 64 IMiDs 64 elotuzumab 64 PharmaVitae Profile 64 Receives Approvable Letter 64 Insegia 64 DPX Survivac 64 LAF# 64 aerosolized AAT 64 Co BMY 64 Vertex hepatitis C 64 Tibotec BVBA 64 docetaxel Taxotere ® 64 LSE ASM 64 Submits Response 64 Pfizer Camptosar 64 Receives Orphan Drug 64 Milestone Payment 64 Xcytrin R 64 Civacir 64 NASDAQ REGN 64 gefitinib Iressa 64 Neulasta R 64 panitumumab Vectibix 64 acetonide FA 64 Receives Milestone Payment 64 Fast Track Status 64 commercialize SGN 64 successfully commercialize Iluvien 64 CYT# potent vascular disrupting 64 Panitumumab 64 Gleevec Glivec 64 Votrient 64 Combination REOLYSIN R 64 Azacitidine 64 ASONEP TM 64 Submits NDA 64 Vidaza ® 64 Eli Lilly Gemzar 64 evaluating T DM1 64 sunitinib Sutent 63 Panzem R NCD 63 Roche OTC RHHBY 63 sunitinib malate 63 PANVAC VF 63 Hormone Refractory Prostate Cancer 63 RANK Ligand inhibitor 63 5 fluorouracil leucovorin 63 Brentuximab Vedotin SGN 63 Begins Dosing 63 Pegasys peginterferon alfa 2a 63 ixabepilone 63 AEGR 63 Roche Xeloda 63 Allos Therapeutics ALTH 63 midstage clinical 63 nilotinib Tasigna 63 iniparib 63 Granted Orphan Drug 63 Sanofi Aventi 63 squamous non 63 Roche ROG.VX 63 Vicriviroc 63 mapatumumab 63 solanezumab 63 Humira adalimumab 63 Orphan Status 63 Seattle Genetics SGEN 63 HGS# 63 Presents Preclinical Data 63 Pivotal Phase 63 bevacizumab Avastin ® 63 Sprycel dasatinib 63 Theratope 63 FEMALES SHOULD BE ADVISED 63 Copegus ribavirin 63 metaglidasen 63 metastatic castration resistant 63 Million Milestone Payment 63 Eloxatin oxaliplatin 63 Cyclacel Pharmaceuticals 63 Personalized Immunotherapy 63 drug Treanda 63 Drug Fails 63 Phase 2b Clinical Trial 63 Immunogen IMGN 63 BARACLUDE R 63 Atripla combines 63 Patient Enrollment 63 erlotinib Tarceva 63 cyclophosphamide chemotherapy 63 Nanobody R 63 Wyeth Enbrel 63 selective estrogen receptor modulator 63 metastatic colorectal 63 Bayer HealthCare Onyx Pharmaceuticals 63 TroVax ® 63 Initiate Phase 63 Launches Generic Version 63 metastatic hormone refractory 63 Receives Positive Opinion 63 Risperidone Oral Solution 63 Boceprevir 63 NASDAQ ACOR 63 NASDAQ PHRM 63 Pravachol pravastatin 63 ® lenalidomide 63 Investigational Compound 63 sargramostim 63 PSMA ADC 63 FOLOTYN ® 63 YONDELIS 63 Jevtana 63 adjuvant colon cancer 63 Hsp# Inhibitor 63 Immunotherapeutic 63 Crofelemer budesonide foam 63 Taxol paclitaxel 63 drug figitumumab 63 oral prodrug 63 Biogen Genentech 63 Arranon 63 oral taxane 63 pertuzumab 63 Taxotere chemotherapy 63 trastuzumab DM1 T DM1 63 AG NOVN.VX 62 Auxilium Pharma 62 Nasdaq ACHN 62 Zavesca r 62 cathepsin K inhibitor 62 alvespimycin 62 Romiplostim 62 Intravenous CP 62 Boehringer Ingelheim MedImmune 62 Gleevec imatinib mesylate 62 Prolongs Survival 62 whose tumors overexpress 62 Pegintron 62 Receive Milestone Payment 62 HuLuc# 62 volociximab 62 cediranib 62 Mylan Receives Approval 62 Amgen Vectibix 62 PDE4 inhibitor 62 Regeneron Pharmaceuticals Inc 62 AstraZeneca Symbicort 62 TKPHF 62 TOCOSOL Camptothecin 62 Patients Treated With 62 oral ridaforolimus 62 Epothilone D 62 ADP receptor antagonist 62 lenalidomide Revlimid 62 Neuvenge 62 Muraglitazar 62 Solaraze 62 Ceflatonin 62 tubulin inhibitor 62 motesanib 62 ALPMF 62 Alnylam Nasdaq ALNY 62 azilsartan medoxomil 62 COLAZAL R 62 Announces Poster Presentations 62 Evoltra ® 62 Alimta pemetrexed 62 Viagra Soft Cialis Soft 62 CONBRIZA 62 Shire plc SHPGY 62 TLK# 62 Submits IND 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 Atelvia 62 plus prednisone prednisolone 62 non nucleoside inhibitor 62 etanercept Enbrel 62 cinacalcet HCl 62 Pivotal Study 62 Genentech Roche 62 ALN PCS 62 Mepact 62 Triapine 62 Vitrasert R 62 Telik logo TELINTRA 62 SinuNase ™ 62 Roche Actemra 62 Novel Oral 62 Uplyso 62 drug belatacept 62 Arthritis Drug 62 Intravitreal 62 Earns Milestone Payment 62 Rituxan rituximab 62 Ziopharm 62 Vaccine Adjuvant 62 Tibotec Therapeutics division 62 Panzem 62 DVAX 62 Exherin 62 AG NVS 62 Neupogen ® 62 cyclophosphamide doxorubicin vincristine 62 Investigational Oral 62 Fluconazole 62 PTK ZK 62 metastatic HER2 negative 62 SAR# [004] 62 Dynepo TM 62 small molecule tyrosine 62 ocrelizumab 62 Successfully Completes Phase 62 motexafin gadolinium Injection 62 HGS ETR2 62 Bristol Myers Squibb Pravachol 62 phase IIb trial 62 Pfizer Selzentry 62 Zorbtive TM 62 OSI Pharma 62 refractory acute lymphoblastic 62 By JAMAAL ABDUL 62 Expanded Indication 62 INCB# [001] 62 Aliskiren 62 OSI Pharmaceuticals OSIP 62 ABGX 62 FDA APPROVES 62 acyclovir Lauriad R 62 PROSTVAC VF 62 Onyx Pharmaceuticals Announces 62 Somatuline Depot 62 UCB Cimzia 62 please visit http:/www.vandapharma.com 62 mycophenolic acid 62 GVAX ® 62 Cloretazine 62 Amigal TM 62 including eniluracil ADH 62 Tezampanel 62 Zidovudine Tablets 61 ® darbepoetin alfa 61 Sensipar R 61 GTC recombinant human 61 Pivotal Phase III 61 Array BioPharma ARRY 61 Syntonix 61 Etravirine 61 Oral Calcitonin 61 Cenestin 61 Aloxi ® 61 anastrozole Arimidex 61 Xarelto rivaroxaban 61 Regeneron Pharmaceuticals REGN 61 PFIZER INC. 61 Cloretazine ® 61 HGS ETR1 mapatumumab 61 atacicept 61 Campto 61 Antitumor Activity 61 sulfonylurea glimepiride 61 Safinamide 61 TRX1 61 Amgen AMGN.O 61 Genentech Rituxan 61 Dealmaking Profile 61 lintuzumab SGN 61 Annamycin 61 Platinol ® cisplatin 61 Isis Pharma 61 Co BMY.N 61 midstage studies 61 Camptosar ® 61 Alkeran 61 Laquinimod 61 forodesine 61 miconazole Lauriad 61 efaproxiral 61 Generic Version 61 NSABP C 61 Bonefos 61 telomerase therapeutic 61 Nasdaq IMGN 61 Luveris 61 Inspire Pharma 61 Affymax AFFY 61 Arimidex anastrozole 61 Treatment Naïve 61 GENR 61 goserelin 61 Thalomid ® 61 CINQUIL 61 Amgen denosumab 61 Alnara Pharmaceuticals 61 blood thinner Xarelto 61 baminercept 61 please visit www.abraxane.com 61 Edurant 61 Xinlay 61 Zybrestat 61 SANOFI AVENTIS 61 L BLP# 61 OvaRex ® MAb 61 novel emulsion formulation 61 initiated Phase Ib 61 liposomal formulation 61 zoledronic acid Reclast 61 DPP4 inhibitor 61 oral picoplatin 61 Study Evaluating 61 tremelimumab 61 REG1 Anticoagulation System 61 Zytiga 61 Anti Tumor 61 IMiDs ® 61 Zemplar 61 Crucell NV NYSE Euronext 61 Triglide 61 Enbrel etanercept 61 Merck KGaA MRK GY 61 TTHI 61 TolerRx 61 GlaxoSmithKline Plc Novartis AG 61 Abiraterone Acetate 61 Immunogen 61 Valeant Pharma 61 Nasdaq PARD 61 FOLFOX6 61 Cetuximab Erbitux 61 THALOMID 61 OMRIX Biopharmaceuticals 61 gemcitabine cisplatin 61 delivers fluocinolone acetonide FA 61 Cancidas 61 NYSE PFE Exelon Rivastigmine 61 GIPET 61 LSE AZN 61 risedronate sodium tablets 61 Paraplatin 61 MEK Inhibitor 61 Idenix Pharma 61 Milestone Payment From 61 please visit http:/www.atherogenics.com 61 Idenix Pharmaceuticals IDIX 61 Alnylam Pharma 61 oral deforolimus 61 SHP LN 61 Glucophage XR 61 Presents Positive 61 rasagiline tablets 61 pegylated liposomal doxorubicin 61 Drug Candidate 61 albiglutide 61 Inc. www.micromet inc.com 61 GW# [003] 61 gastrin analogue TT 61 LymphoStat B TM 61 Sanvar R 61 mitoxantrone plus 61 omacetaxine mepesuccinate 61 entinostat 61 Ocrelizumab 61 Vandetanib 61 Prestara 61 NASDAQ ALXN 61 metastatic castrate resistant 61 MBRX 61 Tocosol Paclitaxel 61 Preotact R 61 Amrubicin 61 German drugmaker Merck 61 ASX PGL 61 PHRM 61 candidate TNFerade biologic 61 sapacitabine CYC# 61 Penwest Pharma 61 Vidaza azacitidine 61 developing ACAPODENE 61 dacetuzumab collaboration 61 please visit http:/www.avastin.com 61 Receives Tentative FDA 61 markets Testim ® 61 Kiadis 61 FUSILEV enhances 61 Tarceva TM 61 ® bortezomib 61 Maribavir 61 sulfonylurea metformin 61 agonistic human 61 estramustine 61 FDA Accepts 61 Merck MRK.N 61 adecatumumab MT# 61 Arzerra ofatumumab 61 ACTEMRA TM 61 Elagolix 61 Amgen Enbrel 61 ticagrelor Brilinta 61 antibody MAb 61 Keryx Biopharma 61 NASDAQ ISTA 61 MKC# MT 61 Lilly Alimta 61 Prodarsan R 61 Fortovase 61 subsidiaries visit http:/www.apricusbio.com 61 Wyeth Progenics 61 ImmunoGen TAP technology 61 Vertex Pharma 61 Glaxosmithkline Plc 61 Ixabepilone 61 bladder ovarian 61 Thiarabine 61 Astex Therapeutics 60 cetuximab Erbitux R 60 oncolytic virus therapies 60 Canaccord Genuity Maintains Hold 60 technology visit http:/www.genmab.com 60 recurrent metastatic ovarian cancer 60 Pegloticase 60 Phase III Trial 60 Phase 1b Clinical Trial 60 non porcine pancreatic 60 NASDAQ PGNX 60 XenoPort NASDAQ XNPT 60 Aryx 60 Targacept TRGT 60 pravastatin Pravachol 60 CDP# 60 Sustiva efavirenz 60 Onyx Pharmaceuticals Inc 60 IL# PE#QQR 60 Medoxomil 60 Kaletra lopinavir ritonavir 60 Entocort 60 First Patient Enrolled 60 Phase 2a Trial 60 erlotinib Tarceva ® 60 Aceon 60 novel VDA molecule 60 ALN VSP Phase 60 XL# anticancer compounds 60 MGd 60 Rilutek 60 MKGAY 60 REMINYL ® 60 Archexin 60 Onyx Pharma 60 Actelion Ltd. 60 Shire SHP.L 60 evaluating picoplatin 60 Inc. NASDAQ SUPG 60 markets HP Acthar 60 RECOTHROM R 60 pharmacogenomic translational research 60 NOVN.VX 60 Nasdaq CADX 60 FS Antihemophilic Factor Recombinant 60 developing ostarine selective 60 GlaxoSmithKline GSK.L 行情 60 EndoTAGTM 1 60 PHX# 60 Ariad Pharma 60 assessing T DM1 60 docetaxel chemotherapy 60 CRXL 60 Onyx Pharmaceuticals ONXX 60 Friedreich Ataxia FRDA 60 midstage trials 60 anthracycline taxane 60 ADR NYSE SNY 60 bosutinib 60 OvaRex R 60 Biogen Idec BIIB.O 60 Straumann Holding AG 60 targeted radiotherapeutic 60 Betaferon R 60 OLEPTRO 60 developer Antisoma plc 60 paclitaxel Taxol 60 pralatrexate injection folate analogue 60 aripiprazole Abilify 60 CIMZIA r 60 Optimer Pharma 60 PrevOnco 60 http:/www.bms.com 60 BRILINTA 60 Targretin capsules 60 Corp. ADLR 60 GSK.L 60 advanced HER2 positive 60 Rigel R# 60 ViroChem Pharma Inc. 60 platelet aggregation inhibitor 60 P#X# antagonist 60 Licenses Novel 60 Previously Treated 60 Zegerid OTC 60 receptor tyrosine kinase inhibitor 60 NASDAQ ALNY 60 generation purine nucleoside 60 Tarceva erlotinib 60 gemcitabine Gemzar 60 deforolimus 60 Neulasta ® 60 docetaxel Taxotere 60 Vaccinex 60 Folfox 60 NASDAQ ONXX 60 alemtuzumab Campath 60 kidney urologic 60 Lupus Drug 60 DU #b 60 Symbicort asthma 60 Inc. Nasdaq IMGN 60 GSK Advair 60 Xanafide 60 RAPTIVA 60 BIIB.O Quote Profile Research 60 Corp. PHRM 60 Dynavax Technologies Corp 60 neratinib 60 Japanese drugmaker Daiichi 60 Peregrine Pharma 60 cMET 60 ospemifene 60 Vytorin combines 60 deCODE ProstateCancer TM 60 Diovan Exforge Tekturna Zelnorm 60 Troxatyl 60 Marketing Authorisation Application 60 pan histone deacetylase 60 Progenics Pharmaceuticals 60 TBC# 60 Curagen 60 Medivation Inc 60 Marqibo TM 60 Noxafil 60 Certican 60 sitaxsentan 60 Aptivus ® 60 Cladribine 60 Inhaled Insulin 60 Epivir HBV 60 Incyte Corp 60 proprietary polysaccharide 60 Gnant consults 60 severe hypercholesterolemia 60 hoFH 60 Fulvestrant 60 Serdolect ® 60 JAK Inhibitor 60 Phase III Trials 60 TSRX 60 MOVIPREP R 60 relapsed MM 60 AVONEX ® 60 cyclophosphamide methotrexate 60 castration resistant hormone refractory 60 dasatinib Sprycel ® 60 Romidepsin 60 Telbivudine 60 Addex Pharmaceuticals SA 60 novel therapeutic antibodies 60 GlycArt 60 BioMarin Pharma 60 Cimzia TM 60 beta 1a 60 Therapeutic Competitors Report 60 Inc FRX 60 SNY SAN.FR 60 NASDAQ ENMD 60 Solazed 60 sirtuin modulators 60 Granulocyte Colony Stimulating Factor 60 Milestone Payments 60 Cephalon NASDAQ CEPH 60 DepoMed 60 NEUPOGEN R 60 REBETOL combination therapy 60 Oncogenex 60 Brovana 60 Alexion Pharma 60 Par Pharmaceutical PRX 60 Celldex Therapeutics NASDAQ CLDX 60 Davanat 60 mertansine 60 humanised monoclonal antibody 60 Teva Copaxone 60 Roche RHHBY 60 paclitaxel Taxol R 60 Rasilez HCT 60 Degarelix 60 Nasdaq VRTX today 60 Initiates Phase 60 NOVN.VX Quote Profile Research 60 Immunomedics IMMU 60 Novo Nordisk NOVOb.CO 60 vapreotide acetate 60 epigenetic therapies 60 nonsedating antihistamine 60 INSPIRE Trial Phase III 60 Ethyol 60 Phase IIb Trial 60 Campath ® 60 Co LLY.N 60 Merck KGaA MRCG.DE 60 OPTR 59 ENZN 59 Lundbeck AS 59 non resectable metastatic 59 ARB telmisartan 59 Antisoma AS# 59 LibiGel transdermal testosterone gel 59 reduce serum phosphate 59 Ceflatonin R 59 Abiraterone acetate 59 registrational trial 59 NASDAQ LGND 59 lenalidomide Revlimid R 59 Tocosol 59 dutogliptin 59 Kinase Inhibitor 59 Elotuzumab 59 Forest Labs FRX 59 PLAVIX ® 59 Abiraterone 59 clodronate 59 Catalyst Biosciences 59 Onco TCS 59 oral methylnaltrexone 59 Olaparib 59 Proellex TM 59 IMGN 59 JOULFERON 59 Ozarelix 59 Nasdaq IDIX 59 fusion enhancers 59 alfa 2a 59 metastatic renal cell 59 psoriasis rheumatoid arthritis 59 Allergan NYSE AGN 59 hormone refractory metastatic prostate 59 metastatic sarcomas 59 Theravance THRX 59 ARIMIDEX 59 Roche Holding AG RHHBY 59 Auxilium Pharmaceuticals Inc 59 FDA Approvals 59 axitinib 59 Schering SHR 59 thetreatment 59 Nasdaq BIIB 59 Renal Cell Carcinoma RCC 59 Sepracor SEPR 59 Inc Therapeutic Competitors 59 CYT# vascular disrupting 59 Hycamtin ® 59 CAPHOSOL R 59 cytokine refractory 59 NYSE Amex YMI 59 MLNM 59 IAP inhibitors 59 GlaxoSmithKline MedImmune 59 developing Bicifadine serotonin 59 Wellstat 59 Aurora Kinase 59 Nichi iko 59 ALN HPN 59 Sanofi Aventis SASY.PA 59 approved incretin mimetic 59 KNS # 59 TRANSDUR ™ 59 pentadentate logo R 59 NOVARTIS 59 Sepracor insomnia 59 Advanced Melanoma 59 FUSILEV ® 59 Remicade infliximab 59 DCVax R 59 ruxolitinib 59 CIMZIA TM 59 inhalable insulin product 59 Refractory Hodgkin Lymphoma 59 corticosteroid dexamethasone 59 Camptosar 59 Myocet 59 Nasdaq CRXL 59 Cimzia certolizumab pegol 59 Completes Enrollment 59 NASDAQ INCY 59 Novartis AG NOVN.VX 59 LungAlert TM 59 Oral Fingolimod 59 BiovaxID TM 59 relapsed acute lymphoblastic 59 compound perifosine 59 Zenpep 59 Ariad Pharmaceuticals 59 Aldara ® 59 JAK2 Inhibitor 59 HER2 amplified 59 Sebivo 59 CIP TRAMADOL ER 59 Novartis NVS Snapshot Report 59 Hydrochlorothiazide Tablets 59 Sunesis Pharma 59 Paris IPN Euronext 59 Asentar 59 Nasdaq BCRX 59 AS# amonafide L malate 59 nasal calcitonin product 59 Viread Emtriva 59 Holding AG ROG.VX 59 Prezista darunavir 59 Orathecin 59 Clinical Trial Results 59 Eloxatin ® 59 DNA demethylating agent 59 Praecis 59 Nasdaq HALO 59 SNT MC# 59 ZADAXIN ® 59 NV1FGF 59 plus prednisone 59 AERx ® 59 RhuDex TM 59 OMNARIS Nasal Spray 59 Inc AMGN AMGN 59 Tasimelteon 59 metastatic colorectal carcinoma 59 Please visit www.antisoma.com 59 IMC #B 59 SHP.L 59 compound INCB# 59 candidate deforolimus 59 Onglyza saxagliptin 59 Trubion Pharmaceuticals TRBN 59 Inc. Alcortin TM 59 HuMax CD# 59 Syncria 59 Ellence 59 PEGylated Fab fragment 59 levetiracetam Keppra 59 Eyetech Pharmaceuticals 59 Pivotal Trial 59 HuMax TAC 59 Serdolect 59 immunotherapeutic vaccine 59 BRAF mutant 59 TNF Tumor Necrosis Factor 59 HuMax 59 Sumatriptan Succinate 59 NPS Pharma 59 pan HDAC inhibitor 59 Ambrisentan 59 Sanofi NYSE SNY 59 Syntonix Pharmaceuticals 59 CRTX 59 Anthracycline 59 DP VPA 59 GILD GILD 59 omalizumab Xolair 59 initiated Phase 1b 59 OvaRex 59 Febuxostat 59 rxRNA 59 Teva Pharma 59 Alnylam #x# 59 enzastaurin 59 Phase Ib II 59 CTRX 59 Celgene Corp CELG.O 59 Locked Nucleic Acid LNA 59 please visit http:/www.astrazeneca-us.com 59 Luveris R Ovidrel R 59 myelodysplastic myeloproliferative diseases 59 TOCOSOL Paclitaxel 59 GILEAD SCIENCES 59 Generx TM 59 Vertex Pharmaceuticals Inc 59 NASDAQ WCRX 59 R memantine HCl 59 refractory metastatic 59 Orphan Drug designation 59 blood thinner prasugrel 59 Simponi golimumab 59 ALNY 59 ARQL 59 BRIM2 59 Adentri 59 pediatric acute lymphoblastic 59 Egrifta 59 Idera Pharmaceuticals 59 Roche Chugai 59 Kos Pharma 59 sarcoma melanoma 59 Quinamed 59 Orencia abatacept 59 phase IIb clinical 59 Impax Laboratories IPXL 59 OMP #R# 59 Release Capsules 59 ZACTIMA 59 Provectus Pharmaceuticals specializes 59 Zemplar Capsules 59 Adenoscan R 59 Sanctura XR 59 Idec Roche Takeda 59 RapidMist 59 Pruvel TM 59 MNTX 59 Omacetaxine 59 Fodosine 59 Nasdaq EPCT 59 Randomized Phase 59 CCR9 antagonist 59 Myriad logo BRACAnalysis 59 Quark Pharmaceuticals 59 Argatroban 59 estrogen receptor antagonist 59 5 FU capecitabine 59 Selective Electrochemical Tumor Ablation 59 Vitaxin 59 Frazer Penn. based 59 resistant hormone refractory 59 subsidiary Mylan Pharmaceuticals 59 Alantos 59 Savient Pharmaceuticals Inc 59 Gentamicin Surgical Implant 59 Stimuvax R 59 bevacizumab Avastin R 59 Nymox Pharmaceutical 59 Nabi HB Intravenous 59 Merck OSI Pharmaceuticals 59 RTP #i 59 OVATURE 59 Prolor Biotech 59 histamine dihydrochloride 59 Novartis AG NVS NOVN.VX 59 PFE PFE 59 Regeneron REGN 59 Epivir 59 Albuferon albinterferon alfa 2b 59 Wyeth Torisel 59 MOGN 59 Sigma Aldrich SIAL 59 danoprevir 59 investigational humanized monoclonal antibody 59 Topiramate Tablets 59 breast cancer pill Tykerb 59 RIGScan CR 59 ProSavin 59 Cleviprex TM clevidipine 59 ThermoDox R 59 Xenoport Inc. 59 atrasentan 59 NASDAQ SGEN 59 Lupuzor 59 Nanobody ® 59 Lamictal ODT 59 Lovaza TM 59 Previously Untreated 59 cisplatin gemcitabine 59 candidates Azedra TM 59 Pirfenidone 59 TRIOLEX HE# APOPTONE HE# 59 highly selective inhibitor 59 HuMax EGFr 59 Psivida 59 Metabasis Therapeutics 59 Curis NASDAQ CRIS 59 MacroMed 59 YONDELIS R 59 Serostim ® 59 Par Pharma 59 NASDAQ CLDX 59 CD# CEA 59 Trubion Pharma 59 Onyx Pharmaceuticals 59 Orphan Designation 59 following fluoropyrimidine oxaliplatin 59 Aplidin 59 substantially excreted 59 SGXP 59 Panzem ® 59 develop HBV reactivation 59 Avanir Pharmaceuticals Inc